Articles tagged with “biotech-ai”

A 2026 guide to AI enablement for biotech covering a 12-week implementation roadmap, workshop pricing from $3,500 to $5,500, a $2.9 billion drug discovery AI market, and FDA and EU AI Act compliance requirements.

Analyze OpenAI's GPT-Rosalind, a biochemical reasoning model for life sciences. Learn how Amgen, Moderna, and Thermo Fisher apply this AI to drug discovery.

Explore shadow AI in biotech and life sciences. This report details unsanctioned generative AI usage, data privacy risks, and enterprise governance strategies.

Learn how to measure AI ROI in drug discovery beyond cost and time savings. Updated for 2026 with 173+ AI clinical programs, Insilico's Phase IIa results, Recursion-Exscientia merger, and new FDA guidance. Key metrics for scientific outcomes, pipeline productivity, and commercial value.

Explore our 2025 analysis of the top 25 pharmaceutical companies by AI patent filings. Learn who leads in AI R&D, key technology areas, and strategic trends.

An in-depth analysis of RLHF platforms for biotech (updated Feb 2026). Compare Scale AI (post-Meta deal), Labelbox, Appen, Surge AI, and in-house solutions on capabilities, cost, and HIPAA compliance.